Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131 | Amalgamated Financial Corp (AMAL) | XNAS | US | 2025-12-31 | 10 hours ago | USD | 41.12 | 44.05 | 107.12% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 132 | Accenture PLC (ACN) | XNYS | IE | 2025-08-31 | 10 hours ago | USD | 240.86 | 113.67 | 47.19% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 133 | ACNB Corp (ACNB) | XNAS | US | 2025-12-31 | 10 hours ago | USD | 52.15 | 57.93 | 111.08% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 134 | Acorda Therapeutics Inc (ACOR) | XNAS | US | 2022-12-31 | 1 year ago | USD | 1.35 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 135 | Ares Commercial Real Estate Corp (ACRE) | XNYS | US | 2024-12-31 | 10 hours ago | USD | 5.75 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 136 | Arcadium Lithium PLC (ALTM) | XNYS | IE | 2024-12-31 | 11 months ago | USD | 5.84 | 11.50 | 196.92% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 137 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 2 years ago | USD | 0.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 138 | Alexander's Inc (ALX) | XNYS | US | 2024-12-31 | 10 hours ago | USD | 233.77 | 101.51 | 43.42% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 139 | AMETEK Inc (AME) | XNYS | US | 2025-12-31 | 9 hours ago | USD | 235.55 | 78.95 | 33.52% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 140 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2024-12-31 | 3 months ago | USD | 0.06 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |